- Home
- PR vs COO Comparison
PR vs COO Comparison
Compare PR & COO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PR | COO |
|---|---|---|
| Founded | 2015 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Ophthalmic Goods |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.0B | 16.5B |
| IPO Year | 2016 | 1994 |
Fundamental Metrics
Financial Performance| Metric | PR | COO |
|---|---|---|
| Price | $19.01 | $75.89 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 15 | 11 |
| Target Price | $19.77 | ★ $90.18 |
| AVG Volume (30 Days) | ★ 12.2M | 1.8M |
| Earning Date | 05-28-2026 | 01-01-0001 |
| Dividend Yield | ★ 3.40% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.28 | 0.66 |
| Revenue | ★ $5,065,211,000.00 | $2,532,800,000.00 |
| Revenue This Year | $5.54 | $6.61 |
| Revenue Next Year | $11.09 | $5.36 |
| P/E Ratio | ★ $14.73 | $40.99 |
| Revenue Growth | 1.29 | ★ 18.41 |
| 52 Week Low | $10.62 | $61.78 |
| 52 Week High | $19.38 | $89.83 |
Technical Indicators
Market Signals| Indicator | PR | COO |
|---|---|---|
| Relative Strength Index (RSI) | 72.20 | 28.96 |
| Support Level | $13.02 | $67.78 |
| Resistance Level | N/A | $84.38 |
| Average True Range (ATR) | 0.58 | 2.02 |
| MACD | 0.02 | -0.84 |
| Stochastic Oscillator | 81.66 | 26.21 |
Price Performance
Historical ComparisonAbout PR Permian Resources Corporation
Permian Resources Corp is an independent oil and natural gas company focused on generating outsized returns to stakeholders through the responsible acquisition, optimization, and development of oil and liquids-rich natural gas assets. The Company's assets and operations are concentrated in the core of the Permian Basin, and its properties consist of large, contiguous acreage blocks located in West Texas and New Mexico.
About COO The Cooper Companies Inc.
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.